1-bromopropane has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Qiu, X; Wang, Q; Wang, S; Xu, L; Zhao, XL | 1 |
Chang, J; Garner, CE; Huang, C; Ichihara, G; Ichihara, S; Ito, H; Kato, M; Sakurai, T; Toyokuni, S; Zhang, L; Zhang, X; Zong, C | 1 |
Chen, JJ; Wang, QH; Xie, KQ; Zhao, XL; Zhong, ZX | 1 |
3 other study(ies) available for 1-bromopropane and Disease Models, Animal
Article | Year |
---|---|
NMDA Receptor Antagonist MK801 Protects Against 1-Bromopropane-Induced Cognitive Dysfunction.
Topics: Animals; Brain; Cognitive Dysfunction; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hydrocarbons, Brominated; Inflammasomes; Male; Maze Learning; Microglia; Neurons; NLR Family, Pyrin Domain-Containing 3 Protein; Nootropic Agents; Random Allocation; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Spatial Memory; Specific Pathogen-Free Organisms | 2019 |
Preliminary characterization of a murine model for 1-bromopropane neurotoxicity: Role of cytochrome P450.
Topics: Animals; Atmosphere Exposure Chambers; Cerebral Cortex; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; Hydrocarbons, Brominated; Injections, Intraperitoneal; Injections, Subcutaneous; Liver; Male; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurons; Neurotoxicity Syndromes; Organ Size; ran GTP-Binding Protein; Solvents; Triazoles | 2016 |
[Development of peripheral neuropathy rat model induced by 1-bromopropane].
Topics: Animals; Disease Models, Animal; Hydrocarbons, Brominated; Male; Peripheral Nervous System Diseases; Rats; Rats, Wistar | 2012 |